Kodak's Altered Image

Recs

0

Eastman Kodak (NYSE: EK) has had a tough decade.

Since peaking in 1996 at $16.2 billion, the company's sales have dropped by more than 17%. Caught flat-footed by consumers moving to digital photography and bombarded by Japanese competitors like Fuji Photo Film (Nasdaq: FUJIY), Eastman Kodak has seen its traditional businesses wither and its Wall Street support fade like a poorly developed photo. The indignity culminated in April of 2004, when Eastman Kodak was booted from the Dow Jones Industrial Average.

Virtually left for dead, Kodak has been working hard since then to remake itself. In late 2003, Kodak CEO Daniel Carp launched a new strategy. Believing that the company had to focus on increasing its presence in the digital arena, he has led Kodak to buttress its business in the commercial, consumer, and medical imaging markets.

Proving that when the going gets tough, the tough go shopping, Kodak has gone on a spree. Spending more than $3 billion, it has aggressively bought up companies in the medical imaging and commercial printing markets. On Monday morning, Kodak announced the latest addition to its menagerie -- a $980 million purchase of Canadian Creo (Nasdaq: CREO), a Canadian software maker for the commercial printing industry.

Thus far, the market has liked what it's seen. Fools who purchased EK shares on news of the Dow Jones dumping have seen their stock go up more than 30%, and those who bought into the ugliness of late 2003 have seen more than 50% in appreciation.

The recovery is in its early stages, but Kodak did announce that full-year revenues for 2004 were up 5% over 2003. This is perhaps a modest figure, although it does represent back-to-back years of revenue growth -- and that hasn't happened since 1996.

Still, Kodak's future is not crystal clear. All of these acquisitions might raise legitimate concerns about whether Kodak has spread itself too thin and gotten into too many dissimilar businesses. What's more, debt is on the way up as the company intends to pay for its Creo acquisition with another $900 million in additional borrowings.

There's no question, then, that the company has bet its future -- or at least its solvency -- on blending these acquisitions together into a solid growth business. It will take time to see whether the moves will work, but in any case, this is certainly not your parents' Eastman Kodak.

Fool contributor Stephen Simpson, CFA, has no ownership interest in any stocks mentioned.

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 490141, ~/Articles/ArticleHandler.aspx, 11/9/2009 7:15:58 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
Which Companies Can Buy It Like Buffett?

Related Tickers

11/6/2009 4:01 PM
EK $4.23 Up +0.04 +0.95%
Eastman Kodak Comp… CAPS Rating: **

Community: Investing Wiki

Term Of The Hour

Efficient market hypothesis: The efficient market hypothesis or efficient market theory states that stock prices perfectly reflect all market information that is known by all investors.

Want to learn more or edit this definition?
Click here to read more!